Research Article
The Single-Nucleotide Polymorphism (SNP) Validity to Detect Omicron Variants
Table 2
Characteristics of the subjects.
| | Characteristics | Subjects (N = 140) N (%) |
| | Gender | | Male | 57 (40.7) | | Female | 83 (59.3) | | Age (years old) | | 0–16 | 20 (14.3) | | 17–33 | 70 (50.0) | | 34–50 | 29 (20.7) | | 51–67 | 16 (11.4) | | ≥68 | 5 (3.6) | | Symptom | | Asymptomatic | 7 (5.0) | | Mild symptom | 129 (92.1) | | Moderate symptom | 2 (1.4) | | Severe symptom | 2 (1.4) | | SNP genotyping Q493R | | Positive | 21 (15.0) | | Negative | 119 (85.0) | | S-gene target failure (SGTF) | | Positive | 127 (90.7) | | Negative | 13 (9.3) | | SNP criterion results | | No omicron (negative SGTF, negative Q493) | 1 (0.7) | | Omicron BA.1 (positive SGTF, positive Q493R) | 9 (6.4) | | Omicron BA.2 (negative SGTF, positive Q493R) | 12 (8.6) | | Omicron BA.4/5 (positive SGTF, negative Q493R) | 118 (84.3) | | WGS criterion results | | Omicron BA.1 | 10 (7.1) | | Omicron BA.2 | 11 (7.9) | | Omicron BA.4/5 | 119 (85.0) |
|
|